Such a shift in the regulatory balance of T cells following IGF1R inhibition has been recognised in several autoimmune conditions including multiple sclerosis (18, 19), rheumatoid arthritis (20, 21) and type I diabetes mellitus (22, 23). This evidence concerns the gene IGF1R and rheumatoid arthritis.